FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry and provides a protective solution to prevent or reduce the severity of reperfusion injury of the brain, which contains magnesium ions and citrate ions, as well as albumin. Osmolality of this solution ranges from 350 to 600 mOsm/l, and the pH value from 7.5 to 7.8.
EFFECT: invention reduces brain damage in the case of cardiogenic shock, severe circulatory failure and cardiopulmonary resuscitation.
9 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MONITORING CARDIOPULMONARY RESUSCITATION EFFICIENCY | 2020 |
|
RU2737915C1 |
| METHOD FOR PREVENTING ISCHEMIC AND REPERFUSION INJURIES OF THE HIPPOCAMPUS NEURONS IN THE POSTRESUSCITATIVE PERIOD | 2019 |
|
RU2707875C1 |
| METHOD OF MOVING A VICTIMS FOR CARDIO-PULMONARY REANIMATION | 2022 |
|
RU2803376C2 |
| DEVICE FOR TREATING INDIVIDUAL SUFFERING IMPAIRED CARDIAC FUNCTION, CARDIAC ARREST, CIRCULATORY ARREST OR APOPLECTIC SHOCK | 2010 |
|
RU2540147C2 |
| METHOD FOR INDIVIDUAL RESUSCITATION | 2014 |
|
RU2559913C1 |
| CARDIOPLEGIC SOLUTION (VERSIONS) | 2014 |
|
RU2574957C1 |
| PROTECTIVE COMPOSITIONS FOR ISCHEMIA/REPERFUSION AND METHODS FOR USING THEM | 2008 |
|
RU2459624C2 |
| WATER-BASE BLOOD SUBSTITUTE SOLUTION, METHOD OF ITS PREPARING | 1994 |
|
RU2142282C1 |
| APPARATUS AND METHOD FOR RESUSCITATION OR PROVISION FOR THE STATE OF TEMPORARY SUSPENSION OF VITAL ACTIVITY IN CARDIAC ARREST, A CLOSURE DEVICE AND A METHOD ASSOCIATED THEREWITH | 2015 |
|
RU2725073C2 |
| METHOD FOR SIMULATING GLOBAL CEREBRAL ISCHEMIA IN SMALL LABORATORY ANIMALS | 2010 |
|
RU2464645C2 |
